- Investing Ideas
- /
- Global Pharmaceuticals & Biotech High Insider Buying
Global Pharmaceuticals & Biotech High Insider Buying
UPDATED May 01, 2024
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
156 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ILMN | US$124.68 | 1.5% | -36.6% | US$19.6b | US$157.12 | PS4.4x | E67.0% | n/a | ||
ELAN | US$13.15 | -1.2% | 43.9% | US$6.5b | US$17.76 | PS1.5x | E89.1% | n/a | ||
1177 | HK$2.70 | 0.7% | -36.3% | HK$49.5b | HK$4.67 | PE24.8x | E15.4% | 1.8% | ||
ABCM | US$23.99 | 0.08% | 54.7% | US$5.5b | US$23.66 | PE1758.5x | E39.3% | 0% | ||
OGN | US$18.83 | 0.6% | -22.3% | US$4.8b | US$21.75 | PE4.7x | E3.8% | 5.9% | ||
HLUN B | kr.34.04 | 3.2% | -2.6% | kr.32.7b | kr.38.71 | PE14.7x | E9.9% | 2.1% | ||
PRGO | US$32.90 | 5.3% | -12.2% | US$4.4b | US$39.72 | PB0.9x | E46.9% | 3.4% | ||
BHVN | US$40.18 | 3.8% | 192.2% | US$3.4b | US$57.89 | PB8.3x | E13.8% | n/a | ||
IOVA | US$12.50 | 6.7% | 91.4% | US$3.3b | US$26.00 | PS2941.9x | E61.7% | n/a | ||
SMMT | US$4.70 | 30.9% | 186.6% | US$2.8b | US$8.00 | PB42.5x | S81.2% | n/a | ||
NAMS | US$21.97 | 0.8% | 56.3% | US$2.0b | US$34.51 | PS140.2x | E23.0% | n/a | ||
512 | HK$4.34 | 7.2% | -16.4% | HK$15.2b | n/a | PE8.1x | E20.0% | 6.0% | ||
2005 | HK$4.78 | 0.4% | -10.5% | HK$14.2b | HK$6.23 | PE10.8x | E15.0% | 3.6% | ||
6660 | HK$8.44 | 0.5% | -79.7% | HK$10.2b | HK$53.03 | PS8x | S56.4% | n/a | ||
ALIF B | kr102.60 | -2.5% | -15.7% | kr12.5b | kr137.00 | PE160.3x | E54.5% | 0.5% | ||
ONT | UK£1.01 | -1.4% | -55.6% | UK£870.3m | UK£2.02 | PS5.1x | E21.1% | n/a | ||
ALXO | US$16.94 | 4.4% | 176.8% | US$859.5m | US$20.17 | PB4.5x | E11.5% | n/a | ||
MSB | AU$1.10 | 20.2% | 14.0% | AU$1.3b | AU$1.10 | PS109.3x | E56.8% | n/a | ||
OABI | US$4.56 | 0% | 39.0% | US$522.2m | US$10.00 | PS15.7x | E18.6% | n/a | ||
LRMR | US$7.35 | 13.8% | 59.8% | US$439.6m | US$19.87 | PB5.7x | E-12.3% | n/a | ||
ANRO | US$16.10 | 13.4% | n/a | US$416.6m | US$33.69 | PE-11.9x | E-19.2% | n/a | ||
RNAC | US$22.64 | 8.3% | n/a | US$402.9m | US$56.25 | PS15.5x | E80.3% | n/a | ||
NYKD | kr13.37 | 0.5% | -46.9% | kr4.4b | kr43.00 | PS29.5x | E-23.5% | n/a | ||
TRDA | US$13.25 | 6.6% | 8.3% | US$384.1m | US$21.00 | PS3.3x | E-1.5% | n/a |